These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 6142756)

  • 1. Chronic GM1 ganglioside treatment reduces dopamine cell body degeneration in the substantia nigra after unilateral hemitransection in rat.
    Toffano G; Savoini GE; Moroni F; Lombardi G; Calzà L; Agnati LF
    Brain Res; 1984 Apr; 296(2):233-9. PubMed ID: 6142756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of GM1 ganglioside treatment on the recovery of dopaminergic nigro-striatal neurons after different types of lesion.
    Toffano G; Agnati LF; Fuxe K; Aldinio C; Consolazione A; Valenti G; Savoini G
    Acta Physiol Scand; 1984 Nov; 122(3):313-21. PubMed ID: 6151339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GM1 ganglioside stimulates the regeneration of dopaminergic neurons in the central nervous system.
    Toffano G; Savoini G; Moroni F; Lombardi G; Calza L; Agnati LF
    Brain Res; 1983 Feb; 261(1):163-6. PubMed ID: 6132660
    [No Abstract]   [Full Text] [Related]  

  • 4. Further studies on the effects of the GM1 ganglioside on the degenerative and regenerative features of mesostriatal dopamine neurons.
    Agnati LF; Fuxe K; Calza L; Goldstein M; Toffano G; Giardino L; Zoli M
    Acta Physiol Scand Suppl; 1984; 532():37-44. PubMed ID: 6594030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of gangliosides on the functional recovery of damaged brain.
    Toffano G; Savoini G; Aldinio C; Valenti G; Dal Toso R; Leon A; Calza L; Zini I; Agnati LF; Fuxe K
    Adv Exp Med Biol; 1984; 174():475-88. PubMed ID: 6741741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The vigilance-promoting drug modafinil counteracts the reduction of tyrosine hydroxylase immunoreactivity and of dopamine stores in nigrostriatal dopamine neurons in the male rat after a partial transection of the dopamine pathway.
    Ueki A; Rosén L; Andbjer B; Finnman UB; Altamimi U; Janson AM; Goldstein M; Agnati LF; Fuxe K
    Exp Brain Res; 1993; 93(2):259-70. PubMed ID: 8098283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gangliosides increase the survival of lesioned nigral dopamine neurons and favour the recovery of dopaminergic synaptic function in striatum of rats by collateral sprouting.
    Agnati LF; Fuxe K; Calza L; Benfenati F; Cavicchioli L; Toffano G; Goldstein M
    Acta Physiol Scand; 1983 Dec; 119(4):347-63. PubMed ID: 6141701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GM1 ganglioside does not stimulate reinnervation of the striatum by substantia nigra grafts.
    Freed WJ
    Brain Res Bull; 1985 Jan; 14(1):91-5. PubMed ID: 3986629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic nicotine treatment counteracts the disappearance of tyrosine-hydroxylase-immunoreactive nerve cell bodies, dendrites and terminals in the mesostriatal dopamine system of the male rat after partial hemitransection.
    Janson AM; Fuxe K; Agnati LF; Kitayama I; Härfstrand A; Andersson K; Goldstein M
    Brain Res; 1988 Jul; 455(2):332-45. PubMed ID: 2900058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of lesions and ganglioside GM1 treatment on striatal polyamine levels and nigral DA neurons. A role of putrescine in the neurotropic activity of gangliosides.
    Agnati LF; Fuxe K; Zini I; Davalli P; Corti A; Calza L; Toffano G; Zoli M; Piccinini G; Goldstein M
    Acta Physiol Scand; 1985 Aug; 124(4):499-506. PubMed ID: 2864781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. tGS ganglioside induces peculiar morphological features in grafted dopaminergic cells and promotes motor recovery in rats with unilateral lesions in the nigrostriatal dopamine pathway.
    Nishino H; Hashitani T; Isobe Y; Furuyama F; Sato H; Kumazaki M; Horikomi K; Awaya A
    Brain Res; 1990 Nov; 534(1-2):73-82. PubMed ID: 1981486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The functional recovery of damaged brain: the effect of GM1 monosialoganglioside.
    Toffano G; Savoini G; Aporti F; Calzolari S; Consolazione A; Maura G; Marchi M; Raiteri M; Agnati LF
    J Neurosci Res; 1984; 12(2-3):397-408. PubMed ID: 6150119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GM1 ganglioside restores dopaminergic neurochemical and morphological markers in aged rats.
    Goettl VM; Wemlinger TA; Duchemin AM; Neff NH; Hadjiconstantinou M
    Neuroscience; 1999; 92(3):991-1000. PubMed ID: 10426539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study.
    Hadjiconstantinou M; Mariani AP; Neff NH
    Brain Res; 1989 Apr; 484(1-2):297-303. PubMed ID: 2565752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GM1 gangliosides stimulate neuronal reorganization and reduce rotational asymmetry after hemitransections of the nigro-striatal pathway.
    Sabel BA; Dunbar GL; Butler WM; Stein DG
    Exp Brain Res; 1985; 60(1):27-37. PubMed ID: 3930279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GM1 ganglioside protects against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse.
    Janson AM; Agnati LF; Fuxe K; Cintra A; Sundstrom E; Zini I; Toffano G; Goldstein M
    Acta Physiol Scand; 1988 Apr; 132(4):587-8. PubMed ID: 3265839
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of L-deprenyl treatment, alone and combined with GM1 ganglioside, on striatal dopamine content and substantia nigra pars compacta neurons.
    Rothblat DS; Schneider JS
    Brain Res; 1998 Jan; 779(1-2):226-30. PubMed ID: 9473679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of anterograde degeneration in brain damaged rats by GM1-gangliosides.
    Sabel BA; DelMastro R; Dunbar GL; Stein DG
    Neurosci Lett; 1987 Jun; 77(3):360-6. PubMed ID: 3614768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal infusion of GD3 and GM1 gangliosides downregulates alpha-synuclein and controls tyrosine hydroxylase gene in a PD model mouse.
    Itokazu Y; Fuchigami T; Morgan JC; Yu RK
    Mol Ther; 2021 Oct; 29(10):3059-3071. PubMed ID: 34111562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GM1 ganglioside rescues substantia nigra pars compacta neurons and increases dopamine synthesis in residual nigrostriatal dopaminergic neurons in MPTP-treated mice.
    Schneider JS; Kean A; DiStefano L
    J Neurosci Res; 1995 Sep; 42(1):117-23. PubMed ID: 8531220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.